E

Enderle, Yeliz Susanne (2018) Dried blood spot techniques for the quantification of endothelin receptor antagonists and phosphodiesterase-5 inhibitors: Development, validation, and clinical application in patients. [Abstract of a medical dissertation]

F

Faller, Christine Katharina (2018) Qualitätssicherung in der ambulanten Rezeptschreibung Auswirkungen einer Fünf-Jahres-Intervention. [Abstract of a medical dissertation]

G

Gottwalt, Katharina (2018) Effekt der CYP3A-Modulatoren Efavirenz, Rifampicin und Voriconazol auf die Midazolamplasmakonzentration unter kontinuierlicher Midazolaminfusion. [Abstract of a medical dissertation]

K

Kreuter, Rebecca Barbara (2018) Abhängigkeit der CYP3A4-Aktivität von Dosis und Infusionsgeschwindigkeit von Voriconazol. [Abstract of a medical dissertation]

P

Petrera, Marilena ; Paleari, Laura ; Clavarezza, Matteo ; Puntoni, Matteo ; Caviglia, Silvia ; Briata, Irene Maria ; Oppezzi, Massimo ; Mihajlovic Mislej, Eva ; Stabuc, Borut ; Gnant, Michael ; Bachleitner-Hofmann, Thomas ; Roth, Wilfried ; Scherer, Dominique ; Haefeli, Walter-E. ; Ulrich, Cornelia M. ; DeCensi, Andrea (2018) The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients. BMC Cancer, 18 (1210). pp. 1-9. ISSN 1471-2407

R

Reinhard, Raphael Regis (2018) Analysis of the time-dependence of the drug-drug interaction between the novel antiretroviral drug rilpivirine and the phosphodiesterase-5 inhibitor tadalafil. [Abstract of a medical dissertation]

Rixecker, Torben M. (2018) Analyse der subzellulären Lokalisation des Transient Receptor Potential Channels M4 (TRPM4) vor und nach Fc-Rezeptor-I-Stimulation in primären peritonealen Mastzellen. [Abstract of a medical dissertation]

T

Tikk, Kaja ; Czock, David ; Haefeli, Walter E. ; Kopp-Schneider, Annette ; Brenner, Hermann (2018) Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms. BMC Cancer, 18 (914). pp. 1-9. ISSN 1471-2407